Emory University’s KALA BIO KALA Stock Holding History

Emory University’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-62	Closed	-$2.12M	–	48
2018 Q2	$2.12M	Sell	62 -9	-13%	-$345K	1.41%	35
2018 Q1	$2.81M	Buy	71 +31	+78%	+$1.18M	2%	7
2017 Q4	$1.83M	Buy	+40	New	+$1.87M	1.57%	29

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Emory University's KALA Position: Q3 2018 in Review

Emory University sold out of KALA BIO (KALA) in Q3 2018, closing a stake of 62 shares — an estimated $2.12M sold.

Emory University first reported a position in KALA in Q4 2017 and held it in 3 quarters. The position peaked at $2.81M in Q1 2018. 59 funds tracked by Wall St. Rank hold KALA as of Q3 2018.

Emory University reported no remaining KALA BIO position as of Q3 2018 after selling out during the quarter.
Emory University sold 62 KALA BIO shares in Q3 2018, an estimated $2.12M.
Emory University first reported a position in KALA BIO in Q4 2017 and held it in 3 quarters.
Emory University's KALA BIO position peaked at $2.81M in Q1 2018.
59 funds tracked by Wall St. Rank held KALA BIO as of Q3 2018.

Based on Emory University's 13F filing for Q3 2018, filed 14 Nov 2018.